United States Biotechnology & Medical Research

Roivant Sciences Ltd (ROIV)

Track

Over the past 90 days, Roivant Sciences Ltd has seen significant insider selling, with a net value of approximately $217.3 million across 37 transactions. No insider purchases were recorded. These sales, involving directors and major stakeholders, coincide with the stock trading near its 52-week high following a positive earnings report in May.
Ticker: ROIV Exchange: NMS
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for Roivant Sciences Ltd. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →
Top insiders
Trades
Fitzgerald Meghan
1 sale — total 100,000 USD
Sale 30 Jun 2026
Value US$2,094,070.25 | Price 379.98 | Shares 37,158
Sale 30 Jun 2026
Value US$503,684.62 | Price 468.08 | Shares 78,019
Sale 30 Jun 2026
Value US$547,469.63 | Price 447.01 | Shares 61,752
Sale 30 Jun 2026
Value US$100,000.00 | Price 35.28 | Shares 1,000
Sale 30 Jun 2026
Value US$100,000.00 | Price 35.28 | Shares 1,000
Proposed sale 30 Jun 2026
Value US$100,000.00 | Price 34.73 | Shares 1,000
Proposed sale 30 Jun 2026
Value US$100,000.00 | Price 34.73 | Shares 1,000
Proposed sale 30 Jun 2026
Value US$100,000.00 | Price 35.45 | Shares 1,000
Sale 29 Jun 2026
Value US$100,000.00 | Price 34.71 | Shares 1,000
Sale 29 Jun 2026
Value US$100,000.00 | Price 34.32 | Shares 1,000
Sale 29 Jun 2026
Value US$100,000.00 | Price 34.59 | Shares 1,000
Sale 29 Jun 2026
Value US$100,000.00 | Price 34.44 | Shares 1,000
Sale 29 Jun 2026
Value US$100,000.00 | Price 34.59 | Shares 1,000
Sale 29 Jun 2026
Value US$100,000.00 | Price 34.44 | Shares 1,000
Sale 29 Jun 2026
Value US$100,000.00 | Price 34.59 | Shares 1,000
Sale 29 Jun 2026
Value US$100,000.00 | Price 34.44 | Shares 1,000
Proposed sale 29 Jun 2026
Value US$604,742.50 | Price 34.07 | Shares 17,750
Sale 26 Jun 2026
Value US$100,000.00 | Price 34.07 | Shares 1,000
Sale 26 Jun 2026
Value US$100,000.00 | Price 33.92 | Shares 1,000
Sale 26 Jun 2026
Value US$100,000.00 | Price 34.07 | Shares 1,000
Sale 26 Jun 2026
Value US$100,000.00 | Price 33.92 | Shares 1,000
Sale 26 Jun 2026
Value US$100,000.00 | Price 34.07 | Shares 1,000
Sale 26 Jun 2026
Value US$100,000.00 | Price 33.92 | Shares 1,000
Sale 26 Jun 2026
Value US$17,040,000.00 | Price 34.08 | Shares 500,000
Proposed sale 26 Jun 2026
Value US$17,039,650.00 | Price 34.08 | Shares 500,000
Sale 25 Jun 2026
Value US$17,065,000.00 | Price 34.13 | Shares 500,000
Proposed sale 25 Jun 2026
Value US$17,066,500.00 | Price 34.13 | Shares 500,000
Sale 24 Jun 2026
Value US$1,549,301.34 | Price 33.51 | Shares 46,234
Sale 24 Jun 2026
Value US$5,081,966.30 | Price 33.05 | Shares 153,766
Proposed sale 24 Jun 2026
Value US$6,631,659.08 | Price 33.16 | Shares 200,000
Sale 22 May 2026
Value US$6,054,000.00 | Price 30.27 | Shares 200,000
Proposed sale 22 May 2026
Value US$6,054,730.92 | Price 30.27 | Shares 200,000
Sale 20 Apr 2026
Value US$5,918,000.00 | Price 29.59 | Shares 200,000
Proposed sale 20 Apr 2026
Value US$5,917,135.05 | Price 29.59 | Shares 200,000
Sale 16 Apr 2026
Value US$8,449,809.84 | Price 29.16 | Shares 289,774
Proposed sale 16 Apr 2026
Value US$8,449,876.49 | Price 29.16 | Shares 289,774
Proposed sale 16 Apr 2026
Value US$8,449,876.49 | Price 29.16 | Shares 289,774
Sale 8 Apr 2026
Value US$384,073.06 | Price 28.37 | Shares 13,538
Proposed sale 8 Apr 2026
Value US$384,035.15 | Price 28.37 | Shares 13,538
Sale 26 Mar 2026
Value US$1,921,500.00 | Price 27.45 | Shares 70,000
Proposed sale 26 Mar 2026
Value US$1,921,458.00 | Price 27.45 | Shares 70,000
Sale 17 Mar 2026
Value US$5,648,000.00 | Price 28.24 | Shares 200,000
Proposed sale 17 Mar 2026
Value US$5,648,836.44 | Price 28.24 | Shares 200,000
Sale 16 Mar 2026
Value US$1,200,573.48 | Price 28.68 | Shares 41,861
Proposed sale 16 Mar 2026
Value US$1,200,498.13 | Price 28.68 | Shares 41,861
Sale 23 Feb 2026
Value US$16,159,098.90 | Price 27.51 | Shares 587,390
Sale 20 Feb 2026
Value US$27,492,361.50 | Price 27.15 | Shares 1,012,610
Proposed sale 20 Feb 2026
Value US$44,032,000.00 | Price 27.52 | Shares 1,600,000
Sale 19 Feb 2026
Value US$38,388,000.00 | Price 27.42 | Shares 1,400,000
Proposed sale 19 Feb 2026
Value US$38,472,000.00 | Price 27.48 | Shares 1,400,000
Sale 13 Feb 2026
Value US$5,298,000.00 | Price 26.49 | Shares 200,000
Proposed sale 13 Feb 2026
Value US$5,298,373.26 | Price 26.49 | Shares 200,000
Sale 13 Feb 2026
Value US$5,962,500.00 | Price 26.50 | Shares 225,000
Sale 13 Feb 2026
Value US$3,994,268.16 | Price 26.49 | Shares 150,784
Sale 13 Feb 2026
Value US$5,962,500.00 | Price 26.50 | Shares 225,000
Sale 13 Feb 2026
Value US$3,994,268.16 | Price 26.49 | Shares 150,784
Sale 13 Feb 2026
Value US$5,962,500.00 | Price 26.50 | Shares 225,000
Sale 13 Feb 2026
Value US$3,994,268.16 | Price 26.49 | Shares 150,784
Sale 12 Feb 2026
Value US$7,359,000.00 | Price 26.76 | Shares 275,000
Sale 12 Feb 2026
Value US$4,008,000.00 | Price 26.72 | Shares 150,000
Sale 12 Feb 2026
Value US$7,359,000.00 | Price 26.76 | Shares 275,000
Sale 12 Feb 2026
Value US$4,008,000.00 | Price 26.72 | Shares 150,000
Sale 12 Feb 2026
Value US$7,359,000.00 | Price 26.76 | Shares 275,000
Sale 12 Feb 2026
Value US$4,008,000.00 | Price 26.72 | Shares 150,000
Sale 11 Feb 2026
Value US$11,334,750.00 | Price 26.67 | Shares 425,000
Sale 11 Feb 2026
Value US$11,334,750.00 | Price 26.67 | Shares 425,000
Sale 11 Feb 2026
Value US$11,334,750.00 | Price 26.67 | Shares 425,000
Sale 9 Feb 2026
Value US$8,985,003.27 | Price 26.47 | Shares 339,441
Proposed sale 9 Feb 2026
Value US$8,985,275.71 | Price 26.47 | Shares 339,441
Sale 12 Jan 2026
Value US$4,384,000.00 | Price 21.92 | Shares 200,000
Proposed sale 12 Jan 2026
Value US$4,383,694.07 | Price 21.92 | Shares 200,000
Sale 31 Dec 2025
Value US$22,122,381.45 | Price 21.71 | Shares 1,018,995
Sale 29 Dec 2025
Value US$6,780,119.02 | Price 21.74 | Shares 311,873
Proposed sale 29 Dec 2025
Value US$6,781,263.07 | Price 21.74 | Shares 311,873
Proposed sale 24 Dec 2025
Value US$1,689,562.50 | Price 22.53 | Shares 75,000
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-07-02 2026-06-30 S Sale
3.5
Fitzgerald Meghan
Non-Executive Director
37,158 +0.6%
379.98
US$2,094,070 		37,158 +0.6% 379.98 US$2,094,070
2026-06-30 2026-06-30 S Sale
1.9
MANCHESTER KEITH S
Non-Executive Director
78,019 -8.2%
468.08
US$503,685 		78,019 -8.2% 468.08 US$503,685
2026-06-30 2026-06-30 S Sale
1.9
MANCHESTER KEITH S
Non-Executive Director
61,752 +20.9%
447.01
US$547,470 		61,752 +20.9% 447.01 US$547,470
2026-06-30 2026-06-30 S Sale
3.3
Gold Daniel Allen
Non-Executive Director
1,000 -0.1%
35.28
US$100,000 		1,000 -0.1% 35.28 US$100,000
2026-06-30 2026-06-30 S Sale
3.4
QVT Financial LP

Director by Deputization
1,000 -0.1%
35.28
US$100,000 		1,000 -0.1% 35.28 US$100,000
2026-06-30 2026-06-30 PrS Proposed sale
3.5
MEGHAN FITZGERALD

Director

Non-Executive Director
1,000
34.73
US$100,000 		1,000 34.73 US$100,000
2026-06-30 2026-06-30 PrS Proposed sale
3.5
MEGHAN FITZGERALD

Director

Non-Executive Director
1,000
34.73
US$100,000 		1,000 34.73 US$100,000
2026-06-30 2026-06-30 PrS Proposed sale
1.9
KEITH S MANCHESTER

Director

Non-Executive Director
1,000
35.45
US$100,000 		1,000 35.45 US$100,000
2026-07-01 2026-06-29 S Sale
0.9
Epperly Melissa B,
Non-Executive Director
1,000 -14.3%
34.71
US$100,000 		1,000 -14.3% 34.71 US$100,000
2026-07-01 2026-06-29 S Sale
0.9
Epperly Melissa B,
Non-Executive Director
1,000 -43.8%
34.32
US$100,000 		1,000 -43.8% 34.32 US$100,000
2026-06-30 2026-06-29 S Sale
1.9
MANCHESTER KEITH S
Non-Executive Director
1,000 -4.2%
34.59
US$100,000 		1,000 -4.2% 34.59 US$100,000
2026-06-30 2026-06-29 S Sale
1.9
MANCHESTER KEITH S
Non-Executive Director
1,000 -1.4%
34.44
US$100,000 		1,000 -1.4% 34.44 US$100,000
2026-06-30 2026-06-29 S Sale
3.3
Gold Daniel Allen
Non-Executive Director
1,000 -4.2%
34.59
US$100,000 		1,000 -4.2% 34.59 US$100,000
2026-06-30 2026-06-29 S Sale
3.3
Gold Daniel Allen
Non-Executive Director
1,000 -1.4%
34.44
US$100,000 		1,000 -1.4% 34.44 US$100,000
2026-06-30 2026-06-29 S Sale
3.4
QVT Financial LP

Director by Deputization
1,000 -4.2%
34.59
US$100,000 		1,000 -4.2% 34.59 US$100,000
2026-06-30 2026-06-29 S Sale
3.4
QVT Financial LP

Director by Deputization
1,000 -1.4%
34.44
US$100,000 		1,000 -1.4% 34.44 US$100,000
2026-06-29 2026-06-29 PrS Proposed sale
0.9
MELISSA EPPERLY

Director

Non-Executive Director
17,750
34.07
US$604,742 		17,750 34.07 US$604,742
2026-06-30 2026-06-26 S Sale
1.9
MANCHESTER KEITH S
Non-Executive Director
1,000 -2.2%
34.07
US$100,000 		1,000 -2.2% 34.07 US$100,000
2026-06-30 2026-06-26 S Sale
1.9
MANCHESTER KEITH S
Non-Executive Director
1,000 -2.0%
33.92
US$100,000 		1,000 -2.0% 33.92 US$100,000
2026-06-30 2026-06-26 S Sale
3.3
Gold Daniel Allen
Non-Executive Director
1,000 -2.2%
34.07
US$100,000 		1,000 -2.2% 34.07 US$100,000
2026-06-30 2026-06-26 S Sale
3.3
Gold Daniel Allen
Non-Executive Director
1,000 -2.0%
33.92
US$100,000 		1,000 -2.0% 33.92 US$100,000
2026-06-30 2026-06-26 S Sale
3.4
QVT Financial LP

Director by Deputization
1,000 -2.2%
34.07
US$100,000 		1,000 -2.2% 34.07 US$100,000
2026-06-30 2026-06-26 S Sale
3.4
QVT Financial LP

Director by Deputization
1,000 -2.0%
33.92
US$100,000 		1,000 -2.0% 33.92 US$100,000
2026-06-29 2026-06-26 S Sale
2.3
Sukhatme Mayukh

President & CIO

Executive Director
500,000 -2.6%
34.08
US$17,040,000 		500,000 -2.6% 34.08 US$17,040,000
2026-06-26 2026-06-26 PrS Proposed sale
2.3
MAYUKH SUKHATME

Officer; Director

Executive Director
500,000
34.08
US$17,039,650 		500,000 34.08 US$17,039,650
2026-06-29 2026-06-25 S Sale
2.3
Sukhatme Mayukh

President & CIO

Executive Director
500,000 -2.6%
34.13
US$17,065,000 		500,000 -2.6% 34.13 US$17,065,000
2026-06-25 2026-06-25 PrS Proposed sale
2.3
MAYUKH SUKHATME

Officer; Director

Executive Director
500,000
34.13
US$17,066,500 		500,000 34.13 US$17,066,500
2026-06-26 2026-06-24 S Sale
2.2
Venker Eric

President & Immunovant CEO

Officer
46,234 -2.8%
33.51
US$1,549,301 		46,234 -2.8% 33.51 US$1,549,301
2026-06-26 2026-06-24 S Sale
2.2
Venker Eric

President & Immunovant CEO

Officer
153,766 -8.5%
33.05
US$5,081,966 		153,766 -8.5% 33.05 US$5,081,966
2026-06-24 2026-06-24 PrS Proposed sale
2.2
Venker Eric

Officer

Officer
200,000
33.16
US$6,631,659 		200,000 33.16 US$6,631,659
2026-05-22 2026-05-22 S Sale
2.2
Venker Eric

President & Immunovant CEO

Officer
200,000 -11.0%
30.27
US$6,054,000 		200,000 -11.0% 30.27 US$6,054,000
2026-05-22 2026-05-22 PrS Proposed sale
2.2
Venker Eric

Officer

Officer
200,000
30.27
US$6,054,731 		200,000 30.27 US$6,054,731
2026-04-22 2026-04-20 S Sale
2.2
Venker Eric

President & Immunovant CEO

Officer
200,000 -10.8%
29.59
US$5,918,000 		200,000 -10.8% 29.59 US$5,918,000
2026-04-20 2026-04-20 PrS Proposed sale
2.2
Venker Eric

Officer

Officer
200,000
29.59
US$5,917,135 		200,000 29.59 US$5,917,135
2026-04-20 2026-04-16 S Sale
2.3
Gline Matthew

CEO

Executive Director
289,774 -1.7%
29.16
US$8,449,810 		289,774 -1.7% 29.16 US$8,449,810
2026-04-16 2026-04-16 PrS Proposed sale
2.3
Gline Matthew

Officer

Officer
289,774
29.16
US$8,449,876 		289,774 29.16 US$8,449,876
2026-04-16 2026-04-16 PrS Proposed sale
2.3
Gline Matthew

Officer

Officer
289,774
29.16
US$8,449,876 		289,774 29.16 US$8,449,876
2026-04-10 2026-04-08 S Sale
Humes Jennifer

Chief Accounting Officer

Officer
13,538 -13.9%
28.37
US$384,073 		13,538 -13.9% 28.37 US$384,073
2026-04-08 2026-04-08 PrS Proposed sale
JENNIFER HUMES

Officer

Officer
13,538
28.37
US$384,035 		13,538 28.37 US$384,035
2026-03-30 2026-03-26 S Sale
3.5
Fitzgerald Meghan
Non-Executive Director
70,000 -62.0%
27.45
US$1,921,500 		70,000 -62.0% 27.45 US$1,921,500
2026-03-26 2026-03-26 PrS Proposed sale
3.5
MEGHAN FITZGERALD

Director

Non-Executive Director
70,000
27.45
US$1,921,458 		70,000 27.45 US$1,921,458
2026-03-19 2026-03-17 S Sale
2.2
Venker Eric

President & Immunovant CEO

Officer
200,000 -10.8%
28.24
US$5,648,000 		200,000 -10.8% 28.24 US$5,648,000
2026-03-17 2026-03-17 PrS Proposed sale
2.2
Venker Eric

Officer

Officer
200,000
28.24
US$5,648,836 		200,000 28.24 US$5,648,836
2026-03-18 2026-03-16 S Sale
0.9
Epperly Melissa B,
Non-Executive Director
41,861 -72.6%
28.68
US$1,200,573 		41,861 -72.6% 28.68 US$1,200,573
2026-03-16 2026-03-16 PrS Proposed sale
0.9
MELISSA B EPPERLY

Director

Non-Executive Director
41,861
28.68
US$1,200,498 		41,861 28.68 US$1,200,498
2026-02-23 2026-02-23 S Sale
1.8
Torti Frank

President and Vant Chair

Officer
587,390 -4.1%
27.51
US$16,159,099 		587,390 -4.1% 27.51 US$16,159,099
2026-02-23 2026-02-20 S Sale
1.8
Torti Frank

President and Vant Chair

Officer
1,012,610 -6.9%
27.15
US$27,492,362 		1,012,610 -6.9% 27.15 US$27,492,362
2026-02-20 2026-02-20 PrS Proposed sale
1.8
FRANK TORTI

Officer

Officer
1,600,000
27.52
US$44,032,000 		1,600,000 27.52 US$44,032,000
2026-02-23 2026-02-19 S Sale
1.8
Torti Frank

President and Vant Chair

Officer
1,400,000 -9.2%
27.42
US$38,388,000 		1,400,000 -9.2% 27.42 US$38,388,000
2026-02-19 2026-02-19 PrS Proposed sale
1.8
FRANK TORTI

Officer

Officer
1,400,000
27.48
US$38,472,000 		1,400,000 27.48 US$38,472,000
2026-02-18 2026-02-13 S Sale
2.2
Venker Eric

President & Immunovant CEO

Officer
200,000 -10.8%
26.49
US$5,298,000 		200,000 -10.8% 26.49 US$5,298,000
2026-02-13 2026-02-13 S Sale
3.3
Gold Daniel Allen
Non-Executive Director
225,000 -1.5%
26.50
US$5,962,500 		225,000 -1.5% 26.50 US$5,962,500
2026-02-13 2026-02-13 S Sale
3.3
Gold Daniel Allen
Non-Executive Director
150,784 -1.0%
26.49
US$3,994,268 		150,784 -1.0% 26.49 US$3,994,268
2026-02-13 2026-02-13 S Sale
1.9
MANCHESTER KEITH S
Non-Executive Director
225,000 -1.5%
26.50
US$5,962,500 		225,000 -1.5% 26.50 US$5,962,500
2026-02-13 2026-02-13 S Sale
1.9
MANCHESTER KEITH S
Non-Executive Director
150,784 -1.0%
26.49
US$3,994,268 		150,784 -1.0% 26.49 US$3,994,268
2026-02-13 2026-02-13 S Sale
3.4
QVT Financial LP

Director by Deputization
225,000 -1.5%
26.50
US$5,962,500 		225,000 -1.5% 26.50 US$5,962,500
2026-02-13 2026-02-13 S Sale
3.4
QVT Financial LP

Director by Deputization
150,784 -1.0%
26.49
US$3,994,268 		150,784 -1.0% 26.49 US$3,994,268
2026-02-13 2026-02-13 PrS Proposed sale
2.2
Venker Eric

Officer

Officer
200,000
26.49
US$5,298,373 		200,000 26.49 US$5,298,373
2026-02-13 2026-02-12 S Sale
3.3
Gold Daniel Allen
Non-Executive Director
275,000 -1.7%
26.76
US$7,359,000 		275,000 -1.7% 26.76 US$7,359,000
2026-02-13 2026-02-12 S Sale
3.3
Gold Daniel Allen
Non-Executive Director
150,000 -0.9%
26.72
US$4,008,000 		150,000 -0.9% 26.72 US$4,008,000
2026-02-13 2026-02-12 S Sale
1.9
MANCHESTER KEITH S
Non-Executive Director
275,000 -1.7%
26.76
US$7,359,000 		275,000 -1.7% 26.76 US$7,359,000
2026-02-13 2026-02-12 S Sale
1.9
MANCHESTER KEITH S
Non-Executive Director
150,000 -0.9%
26.72
US$4,008,000 		150,000 -0.9% 26.72 US$4,008,000
2026-02-13 2026-02-12 S Sale
3.4
QVT Financial LP

Director by Deputization
275,000 -1.7%
26.76
US$7,359,000 		275,000 -1.7% 26.76 US$7,359,000
2026-02-13 2026-02-12 S Sale
3.4
QVT Financial LP

Director by Deputization
150,000 -0.9%
26.72
US$4,008,000 		150,000 -0.9% 26.72 US$4,008,000
2026-02-13 2026-02-11 S Sale
3.3
Gold Daniel Allen
Non-Executive Director
425,000 -2.6%
26.67
US$11,334,750 		425,000 -2.6% 26.67 US$11,334,750
2026-02-13 2026-02-11 S Sale
1.9
MANCHESTER KEITH S
Non-Executive Director
425,000 -2.6%
26.67
US$11,334,750 		425,000 -2.6% 26.67 US$11,334,750
2026-02-13 2026-02-11 S Sale
3.4
QVT Financial LP

Director by Deputization
425,000 -2.6%
26.67
US$11,334,750 		425,000 -2.6% 26.67 US$11,334,750
2026-02-11 2026-02-09 S Sale
2.3
Sukhatme Mayukh

President & CIO

Executive Director
339,441 -1.7%
26.47
US$8,985,003 		339,441 -1.7% 26.47 US$8,985,003
2026-02-09 2026-02-09 PrS Proposed sale
2.3
Sukhatme Mayukh

Officer

Officer
339,441
26.47
US$8,985,276 		339,441 26.47 US$8,985,276
2026-01-14 2026-01-12 S Sale
2.2
Venker Eric

President & Immunovant CEO

Officer
200,000 -10.8%
21.92
US$4,384,000 		200,000 -10.8% 21.92 US$4,384,000
2026-01-12 2026-01-12 PrS Proposed sale
2.2
Venker Eric

Officer

Officer
200,000
21.92
US$4,383,694 		200,000 21.92 US$4,383,694
2025-12-31 2025-12-31 S Sale
2.3
Sukhatme Mayukh

President & CIO

Executive Director
1,018,995 -4.8%
21.71
US$22,122,381 		1,018,995 -4.8% 21.71 US$22,122,381
2025-12-31 2025-12-29 S Sale
2.3
Sukhatme Mayukh

President & CIO

Executive Director
311,873 -1.6%
21.74
US$6,780,119 		311,873 -1.6% 21.74 US$6,780,119
2025-12-29 2025-12-29 PrS Proposed sale
2.3
Sukhatme Mayukh

Officer

Officer
311,873
21.74
US$6,781,263 		311,873 21.74 US$6,781,263
2025-12-29 2025-12-24 PrS Proposed sale
2.2
ERIC VENKER

Officer

Officer
75,000
22.53
US$1,689,562 		75,000 22.53 US$1,689,562
Explore more

More insider trading research around Roivant Sciences Ltd

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America